1.
Report Overview
1.1.
Report Description
1.2.
Research Methods
1.3.
Research Approaches
2.
Executive Summary
3.
Market Overview
3.1.
Introduction
3.2.
Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3.
PEST-Analysis
3.4.
Porter's Diamond Model for China Angioedema
Treatment Market
3.5.
IGR-Growth Matrix Analysis
3.6.
Competitive Landscape in China Angioedema
Treatment Market
4.
China Angioedema Treatment Market
by Drugs Type
4.1.
C1 Esterase Inhibitor
4.1.1. Cinryze
4.1.2. Berinert
4.1.3. Ruconest
4.1.4. Haegarda
4.2.
Selective Bradykinin B2 Receptor Antagonist
4.2.1. Firazyr
4.3.
Kallikrein Inhibitor
4.3.1. Kalbitor
5.
China Angioedema Treatment Market
by Route of Administration
5.1.
Oral
5.2.
Injections
6.
China Angioedema Treatment Market
by End-user
6.1.
Hospitals
6.2.
Clinics
6.3.
Research Organizations
7.
Company Profiles
7.1.
Manufacturer's & Suppliers
7.1.1. Company 1
7.1.2. Company 2
7.1.3. Company 3
7.1.4. Company 4
7.1.5. Company 5
7.2.
Dealer's / Distributor's Profile
7.2.1. Dealer's /
Distributor's 1
7.2.2. Dealer's /
Distributor's 2
7.2.3. Dealer's /
Distributor's 3
7.2.4. Dealer's /
Distributor's 4
7.2.5. Dealer's /
Distributor's 5
7.2.6. Dealer's /
Distributor's 6
7.2.7. Dealer's /
Distributor's 7
7.2.8. Dealer's /
Distributor's 8
7.2.9. Dealer's /
Distributor's 9
7.2.10.
Dealer's / Distributor's 10
1.
Report Overview
1.1.
Report Description
1.2.
Research Methods
1.3.
Research Approaches
2.
Executive Summary
3.
Market Overview
3.1.
Introduction
3.2.
Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3.
PEST-Analysis
3.4.
Porter's Diamond Model for China Angioedema
Treatment Market
3.5.
IGR-Growth Matrix Analysis
3.6.
Competitive Landscape in China Angioedema
Treatment Market
4.
China Angioedema Treatment Market
by Drugs Type
4.1.
C1 Esterase Inhibitor
4.1.1. Cinryze
4.1.2. Berinert
4.1.3. Ruconest
4.1.4. Haegarda
4.2.
Selective Bradykinin B2 Receptor Antagonist
4.2.1. Firazyr
4.3.
Kallikrein Inhibitor
4.3.1. Kalbitor
5.
China Angioedema Treatment Market
by Route of Administration
5.1.
Oral
5.2.
Injections
6.
China Angioedema Treatment Market
by End-user
6.1.
Hospitals
6.2.
Clinics
6.3.
Research Organizations
7.
Company Profiles
7.1.
Manufacturer's & Suppliers
7.1.1. Company 1
7.1.2. Company 2
7.1.3. Company 3
7.1.4. Company 4
7.1.5. Company 5
7.2.
Dealer's / Distributor's Profile
7.2.1. Dealer's /
Distributor's 1
7.2.2. Dealer's /
Distributor's 2
7.2.3. Dealer's /
Distributor's 3
7.2.4. Dealer's /
Distributor's 4
7.2.5. Dealer's /
Distributor's 5
7.2.6. Dealer's /
Distributor's 6
7.2.7. Dealer's /
Distributor's 7
7.2.8. Dealer's /
Distributor's 8
7.2.9. Dealer's /
Distributor's 9
7.2.10.
Dealer's / Distributor's 10